Contemporary OB/GYN week in review: Maternal mortality, preeclampsia, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: Maternal mortality, preeclampsia, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, April 15 - Friday, April 19 2024), and click each link to read and watch anything you may have missed.
1.) Rising US maternal mortality: Impact of surveillance practices
A recent study highlighted factors impacting increased maternal mortality rates in the United States, shedding light on the repercussions of altered surveillance methods on statistics accuracy.
Click here for the full article.
2.) Study finds maternal vascular indices predict preeclampsia at 36 weeks
Discover how maternal vascular indices at 35 to 37 weeks' gestation offer crucial predictive value for identifying preeclampsia risk.
Click here for the full article.
3.) Study finds reduced CIN3+ risk from early HPV vaccination
A recent study found that human papillomavirus vaccination when aged under 20 years, coupled with active surveillance for cervical intraepithelial neoplasia grade 2, significantly lowers the risk of cervical intraepithelial neoplasia grade 3 or cervical cancer.
Click here for the full article.
4.) The benefits of concurrent fetal and maternal heart rate monitoring
A recent study revealed that employing maternal heart rate monitoring alongside fetal heart rate monitoring during labor significantly decreases the incidence of neonatal encephalopathy and severe neonatal acidemia.
Click here for the full article.
5.) Understanding combined oral contraceptives and breast cancer risk
Mitchell Creinin, MD, sheds lights on the association between combined oral contraceptives and breast cancer risk, offering valuable insights for clinicians and patients alike.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Recap on reproductive rights with David Hackney, MD, MS
December 20th 2022In this episode of Pap Talk, we spoke with David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of ACOG's Ohio chapter for a full recap of where restrictions on reproductive rights have been and where they're going.
Listen
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More
